Bayesian Capital Management’s Confluent CFLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-34,343
Closed -$856K 567
2025
Q2
$856K Sell
34,343
-21,000
-38% -$473K 0.14% 203
2025
Q1
$1.3M Sell
55,343
-58,300
-51% -$1.69M 0.21% 130
2024
Q4
$3.18M Buy
113,643
+58,100
+105% +$1.56M 0.39% 69
2024
Q3
$1.13M Buy
+55,543
New +$1.24M 0.13% 221
2024
Q2
Sell
-202,000
Closed -$6.17M 781
2024
Q1
$6.17M Buy
202,000
+139,000
+221% +$3.92M 0.59% 30
2023
Q4
$1.47M Buy
+63,000
New +$1.52M 0.16% 167
2023
Q1
Sell
-9,180
Closed -$204K 814
2022
Q4
$204K Buy
+9,180
New +$213K 0.03% 595
2022
Q3
Sell
-18,092
Closed -$420K 732
2022
Q2
$420K Buy
+18,092
New +$487K 0.08% 380

Other funds holding CFLT

Bayesian Capital Management's CFLT Position: Q3 2025 in Review

Bayesian Capital Management sold out of Confluent (CFLT) in Q3 2025, closing a stake of 34,343 shares — an estimated $856K sold.

Bayesian Capital Management first reported a position in CFLT in Q2 2022 and held it in 8 quarters. The position peaked at $6.17M in Q1 2024. 385 funds tracked by Wall St. Rank hold CFLT as of Q3 2025.

  • Bayesian Capital Management reported no remaining Confluent position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 34,343 Confluent shares in Q3 2025, an estimated $856K.
  • Bayesian Capital Management first reported a position in Confluent in Q2 2022 and held it in 8 quarters.
  • Bayesian Capital Management's Confluent position peaked at $6.17M in Q1 2024.
  • 385 funds tracked by Wall St. Rank held Confluent as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.